文献速递肿瘤 PET/CT

⁶⁸Ga-FAPI PET/CT检出极罕见直肠癌前列腺转移

Extremely Rare Prostate Metastasis From Rectal Carcinoma Detected on ⁶⁸Ga-FAPI PET/CT.
PubMed 文献 · Clin Nucl Med · 2026-04-27

本文报道一例52岁直肠腺癌经多模式治疗后的患者,因下尿路症状和血肌酐逐渐升高就诊,PSA正常、结肠镜未见局部复发但CEA升高;全身⁶⁸Ga-FAPI PET/CT显示整个前列腺弥漫均匀摄取,前列腺活检证实为直肠原发腺癌转移。

要点

  • 直肠癌前列腺转移多为局部直接蔓延,真正远处转移罕见
  • PSA正常、结肠镜阴性但CEA升高时需警惕不典型转移
  • ⁶⁸Ga-FAPI PET/CT可显示前列腺弥漫均匀摄取,活检可确诊

核心结论

  • 直肠腺癌可发生极罕见的前列腺远处转移,⁶⁸Ga-FAPI PET/CT可检出整个前列腺弥漫均匀摄取并引导活检确诊。

研究设计与样本

  • 个案报道:一例52岁男性直肠腺癌患者,既往接受多模式治疗,因下尿路症状和血肌酐逐渐升高就诊。

主要发现

  • 患者PSA在正常范围内,结肠镜未见局部复发证据,但CEA水平升高。
  • 全身⁶⁸Ga-FAPI PET/CT显示整个前列腺弥漫、均匀的示踪剂摄取。
  • 随后前列腺活检证实为直肠原发腺癌转移。

临床怎么用

  • 直肠癌治疗后出现下尿路症状、血肌酐升高且CEA升高而PSA正常、结肠镜阴性时,应考虑前列腺转移的可能。
  • ⁶⁸Ga-FAPI PET/CT可用于评估此类不典型转移,前列腺活检可明确诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Metastatic involvement of the prostate from colorectal adenocarcinoma is uncommon and usually results from direct local extension rather than true distant metastatic spread. We report the case of a 52-year-old man with a prior history of rectal adenocarcinoma treated with multimodality therapy. He presented with lower urinary tract symptoms accompanied by progressively rising serum creatinine levels. PSA levels were within normal limits, and colonoscopy revealed no evidence of local recurrence; however, CEA levels were elevated. Whole-body ⁶⁸Ga-FAPI PET/CT revealed diffuse, homogeneous tracer uptake involving the entire prostate gland. Subsequent prostate biopsy confirmed metastatic adenocarcinoma from a rectal primary.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Bambhroliya P, Subudhi TK, Mandal S, et al. Extremely Rare Prostate Metastasis From Rectal Carcinoma Detected on ⁶⁸Ga-FAPI PET/CT. Clin Nucl Med. 2026. PMID: 42523055. doi:10.1097/RLU.0000000000006491

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。